Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.160
-0.040 (-1.82%)
Nov 21, 2024, 3:52 PM EST - Market closed
Lexaria Bioscience Balance Sheet
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | May '24 May 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | Aug '19 Aug 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 8.46 | 1.35 | 5.81 | 10.92 | 1.29 | 1.29 | Upgrade
|
Short-Term Investments | 0.05 | 0.13 | 0.35 | 0.83 | 0.02 | 0.06 | Upgrade
|
Cash & Short-Term Investments | 8.51 | 1.48 | 6.16 | 11.75 | 1.31 | 1.35 | Upgrade
|
Cash Growth | 147.72% | -76.01% | -47.58% | 794.97% | -2.69% | -22.33% | Upgrade
|
Accounts Receivable | 0.09 | 0.07 | 0.12 | 0.02 | 0.23 | 0.11 | Upgrade
|
Other Receivables | 0.12 | 0.1 | 0.08 | 0.33 | 0.09 | 0.16 | Upgrade
|
Receivables | 0.21 | 0.18 | 0.2 | 0.34 | 0.31 | 0.27 | Upgrade
|
Inventory | - | - | 0.04 | 0.03 | 0.12 | 0.13 | Upgrade
|
Prepaid Expenses | 0.38 | 0.55 | 0.58 | 0.32 | 0.18 | 0.07 | Upgrade
|
Total Current Assets | 9.09 | 2.2 | 6.98 | 12.44 | 1.93 | 1.82 | Upgrade
|
Property, Plant & Equipment | 0.36 | 0.42 | 0.37 | 0.46 | 0.61 | 0.59 | Upgrade
|
Other Intangible Assets | 0.5 | 0.46 | 0.49 | 0.36 | 0.29 | 0.27 | Upgrade
|
Other Long-Term Assets | 0.06 | - | - | - | - | - | Upgrade
|
Total Assets | 10.02 | 3.08 | 7.83 | 13.27 | 2.83 | 2.68 | Upgrade
|
Accounts Payable | 0.12 | 0.23 | 0.12 | 0.06 | 0.05 | 0.03 | Upgrade
|
Accrued Expenses | 0.01 | 0.01 | 0.03 | 0.05 | 0.1 | 0.15 | Upgrade
|
Short-Term Debt | - | - | - | 0.01 | - | - | Upgrade
|
Current Portion of Leases | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | - | Upgrade
|
Current Income Taxes Payable | - | - | - | 0 | 0 | - | Upgrade
|
Current Unearned Revenue | - | - | - | - | 0.04 | - | Upgrade
|
Total Current Liabilities | 0.16 | 0.27 | 0.19 | 0.15 | 0.23 | 0.18 | Upgrade
|
Long-Term Debt | - | - | - | - | 0.03 | - | Upgrade
|
Long-Term Leases | 0.12 | 0.14 | 0.01 | 0.05 | 0.09 | - | Upgrade
|
Total Liabilities | 0.27 | 0.4 | 0.2 | 0.2 | 0.35 | 0.18 | Upgrade
|
Common Stock | 0.02 | 0.01 | 0.01 | 0.01 | 0 | 0.08 | Upgrade
|
Additional Paid-In Capital | 59.5 | 48.8 | 47.04 | 45.09 | 30.32 | 26.17 | Upgrade
|
Retained Earnings | -49.37 | -45.76 | -39.1 | -31.83 | -27.8 | -23.87 | Upgrade
|
Comprehensive Income & Other | -0.02 | - | - | - | - | - | Upgrade
|
Total Common Equity | 10.12 | 3.04 | 7.95 | 13.27 | 2.53 | 2.38 | Upgrade
|
Minority Interest | -0.38 | -0.36 | -0.32 | -0.2 | -0.04 | 0.11 | Upgrade
|
Shareholders' Equity | 9.75 | 2.68 | 7.63 | 13.06 | 2.48 | 2.49 | Upgrade
|
Total Liabilities & Equity | 10.02 | 3.08 | 7.83 | 13.27 | 2.83 | 2.68 | Upgrade
|
Total Debt | 0.14 | 0.16 | 0.05 | 0.1 | 0.16 | - | Upgrade
|
Net Cash (Debt) | 8.36 | 1.31 | 6.11 | 11.65 | 1.16 | 1.35 | Upgrade
|
Net Cash Growth | 156.64% | -78.50% | -47.57% | 907.31% | -14.26% | -22.33% | Upgrade
|
Net Cash Per Share | 0.80 | 0.20 | 1.04 | 2.65 | 0.42 | 0.52 | Upgrade
|
Filing Date Shares Outstanding | 15.81 | 10.28 | 5.95 | 5.73 | 3 | 2.63 | Upgrade
|
Total Common Shares Outstanding | 15.81 | 8.09 | 5.95 | 5.73 | 3 | 2.63 | Upgrade
|
Working Capital | 8.94 | 1.93 | 6.78 | 12.29 | 1.7 | 1.63 | Upgrade
|
Book Value Per Share | 0.64 | 0.38 | 1.34 | 2.32 | 0.84 | 0.91 | Upgrade
|
Tangible Book Value | 9.62 | 2.58 | 7.46 | 12.9 | 2.23 | 2.12 | Upgrade
|
Tangible Book Value Per Share | 0.61 | 0.32 | 1.25 | 2.25 | 0.74 | 0.81 | Upgrade
|
Machinery | 0.47 | 0.47 | 0.44 | 0.39 | 0.39 | 0.39 | Upgrade
|
Leasehold Improvements | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.